Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subharmonic Contrast Ultrasound for Adnexal Masses
NCT03297112Phase 1Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Aug 2017
- Primary completion
- Sep 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of perflutren lipid microspheres in adnexal mass, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoints: Diagnostic Accuracy of Subharmonic Ultrasound Imaging Compared to Standard Ultrasound or Contrast Enhanced Magnetic Resonance Imaging (MRI) and Accuracy of SHI Characterization Compared to the Risk of Malignancy Index. Started Aug 2017; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
adnexal mass
Beyond the preview
Go deeper on NCT03297112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03297112.